hepatitis-a virus (inactivated) / hepatitis-b surface antigen (twinrix) Report issue

Vaccine Approved FDA
AACT

Active Ingredient History

NOW
  • Now
Combined hepatitis A and B vaccine, is used to provide protection against hepatitis A and hepatitis B. It is given by injection into muscle.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

combined hepatitis a and b vaccine | hepatitis a and b vaccine | hepatitis a & b vaccine | hepatitis-a virus (inactivated) / hepatitis-b surface antigen | hepatitis-a virus(inactivated) / hepatitis-b surface antigen | hepatitisa virus (inactivated) / hepatitis b surface antigen

Organizations (13)

Research & Development (12)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (13)

Approved Indications (2)


 

Hepatitis A (approved 2001)

Hepatitis B (approved 2001)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Bipolar Disorder (Phase 2)

Depression (Phase 2)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

HIV Infections (Phase 2)

Liver Cirrhosis (Phase 2)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 3)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Substance-Related Disorders (Phase 2)

Vaccination (Phase 2)

Vaccines (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial Organizations: 12

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue